Neo Ivy Capital Management’s Oscar Health OSCR Stock Holding History

Neo Ivy Capital Management’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.1M	Sell	270,126 -161,046	-37%	-$2.27M	0.82%	23
2025 Q4	$6.2M	Buy	431,172 +264,812	+159%	+$4.58M	0.98%	18
2025 Q3	$3.15M	Buy	166,360 +77,680	+88%	+$1.28M	0.77%	29
2025 Q2	$1.9M	Buy	+88,680	New	+$1.32M	0.61%	52
2025 Q1	–	Sell	-26,727	Closed	-$359K	–	390
2024 Q4	$359K	Sell	26,727 -1,539	-5%	-$24.8K	0.07%	199
2024 Q3	$600K	Buy	+28,266	New	+$509K	0.19%	178

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neo Ivy Capital Management's OSCR Position: Q1 2026 in Review

Neo Ivy Capital Management reduced its Oscar Health (OSCR) stake by 37% in Q1 2026, selling an estimated $2.27M and leaving 270,126 shares worth $3.1M. The position accounts for 0.82% of the portfolio, ranked #23.

Neo Ivy Capital Management first reported a position in OSCR in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.2M in Q4 2025. 331 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

Neo Ivy Capital Management held 270,126 shares of Oscar Health worth $3.1M as of Q1 2026.
Neo Ivy Capital Management sold 161,046 Oscar Health shares in Q1 2026, an estimated $2.27M.
Oscar Health made up 0.82% of Neo Ivy Capital Management's portfolio in Q1 2026, its #23 holding.
Neo Ivy Capital Management first reported a position in Oscar Health in Q3 2024 and has held it in 6 quarters since.
Neo Ivy Capital Management's Oscar Health position peaked at $6.2M in Q4 2025.
331 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.